HCAT on Nasdaq
Health Catalyst, Inc.
We are a leading provider of data and analytics technology and services to healthcare organizations.4 From its latest annual report
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with HEALTHSTREAM INC, Eventbrite or Yalla Group Ltd, or pick any stock.
- TickerHCAT on Nasdaq2
- IndustryServices-Computer Programming, Data Processing, Etc.2
- HeadquartersSouth Jordan, United States2
- Incorporated inDE3
- Business address10897 South River Front Parkway, #300, South Jordan, Ut 840953
- Filer categoryAccelerated filer3
- Legal formCorporation2
- LEI549300223PL6GWKVJG922
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 50402212
See how the biggest companies compare on our leaderboards
We are a leading provider of data and analytics technology and services to healthcare organizations. Our Solution comprises our cloud-based data and analytics platform, software applications, and expertise. Our clients, which are primarily healthcare providers, use our Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements. We envision a future where all healthcare decisions are data-informed.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Recurring Technology brought in 40% of the revenue Health Catalyst, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Recurring Technology | $187.2M | $194.9M | $208.3M |
| Technology | $187.6M | $194.9M | $208.3M |
| Professional Services | $108.4M | $111.7M | $102.9M |
Business segments
Technology brought in 67% of the revenue Health Catalyst, Inc. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Technology | $187.6M | $194.9M | $208.3M |
| Professional Services | $108.4M | $111.7M | $102.9M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Research and development16¢$49.8M
- Other costs84¢$260.6M
- Income tax0¢$716.0K
Out of $311.1M in revenue.5 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending16¢$968.0K
- Share buybacks84¢$5.0M
Out of $731.0K of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.5
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $311.1M | $306.6M | $295.9M |
| Total cost of revenue, excluding depreciation and amortization | $159.5M | $165.8M | $164.1M |
| Sales and marketing | $52.5M | $54.4M | $67.3M |
| Research and development | $49.8M | $58.0M | $72.6M |
| General and administrative | $49.6M | $56.8M | $76.6M |
| Depreciation and amortization | $50.5M | $41.4M | $42.2M |
| Impairment of goodwill and intangible assets | $110.2M | $0 | $0 |
| Total operating expenses | $312.5M | $210.6M | $258.7M |
| Loss from operations | -$160.9M | -$69.8M | -$126.9M |
| Interest and other (expense) income, net | -$16.4M | $637.0K | $9.1M |
| Loss before income taxes | -$177.3M | -$69.2M | -$117.8M |
| Income tax provision | $716.0K | $333.0K | $356.0K |
| Net loss | -$178.0M | -$69.5M | -$118.1M |
| Net loss per share, basic (in USD per share) | -$2.55 | -$1.15 | -$2.09 |
| Net loss per share, diluted (in USD per share) | -$2.55 | -$1.15 | -$2.09 |
| Weighted-average shares outstanding used in calculating net loss per share, basic (in shares) | 69.9M shares | 60.2M shares | 56.4M shares |
| Weighted-average shares outstanding used in calculating net loss per share, diluted (in shares) | 69.9M shares | 60.2M shares | 56.4M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $50.8M | $249.6M | ||
| Short-term investments | $44.9M | $142.4M | ||
| Accounts receivable, net | $59.1M | $57.2M | ||
| Prepaid expenses and other assets | $14.4M | $16.5M | ||
| Total current assets | $169.3M | $465.6M | ||
| Property and equipment, net | $33.8M | $29.4M | ||
| Intangible assets, net | $77.7M | $86.1M | ||
| Operating lease right-of-use assets | $6.6M | $12.1M | ||
| Goodwill | $209.1M | $259.8M | $190.7M | |
| Other assets | $6.1M | $6.0M | ||
| Total assets | $502.6M | $858.9M | ||
| Accounts payable | $9.4M | $11.4M | ||
| Accrued liabilities | $18.7M | $26.3M | ||
| Deferred revenue | $56.1M | $53.3M | ||
| Operating lease liabilities | $3.8M | $3.6M | ||
| Current portion of long-term debt | $1.6M | $231.2M | ||
| Total current liabilities | $89.6M | $325.9M | ||
| Long-term debt, net of current portion | $151.6M | $151.2M | ||
| Deferred revenue, net of current portion | $410.0K | $249.0K | ||
| Operating lease liabilities, net of current portion | $14.2M | $16.3M | ||
| Contingent consideration liabilities, net of current portion | $250.0K | $0 | ||
| Other liabilities | $798.0K | $154.0K | ||
| Total liabilities | $256.9M | $493.7M | ||
| Preferred stock, $0.001 par value per share; 25,000,000 shares authorized and no shares issued and outstanding as of December 31, 2025 and 2024 | $0 | $0 | ||
| Common stock, $0.001 par value per share, and additional paid-in capital; 500,000,000 shares authorized as of December 31, 2025 and 2024; 72,027,332 and 64,043,799 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $1.6B | $1.6B | ||
| Accumulated deficit | -$1.4B | -$1.2B | ||
| Accumulated other comprehensive income (loss) | $1.6M | -$835.0K | ||
| Total stockholders equity | $245.8M | $365.2M | $366.9M | $425.0M |
| Total liabilities and stockholders equity | $502.6M | $858.9M | ||
| Preferred stock, par value (in USD per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 25.0M shares | 25.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in USD per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in shares) | 500.0M shares | 500.0M shares | ||
| Common stock, shares issued (in shares) | 72.0M shares | 64.0M shares | ||
| Common stock, shares, outstanding (in shares) | 72.0M shares | 64.0M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $50.8M | $249.6M | ||
| Short-term investments | $44.9M | $142.4M | ||
| Accounts receivable, net | $59.1M | $57.2M | ||
| Prepaid expenses and other assets | $14.4M | $16.5M | ||
| Total current assets | $169.3M | $465.6M | ||
| Property and equipment, net | $33.8M | $29.4M | ||
| Intangible assets, net | $77.7M | $86.1M | ||
| Operating lease right-of-use assets | $6.6M | $12.1M | ||
| Goodwill | $209.1M | $259.8M | $190.7M | |
| Other assets | $6.1M | $6.0M | ||
| Total assets | $502.6M | $858.9M | ||
| Accounts payable | $9.4M | $11.4M | ||
| Accrued liabilities | $18.7M | $26.3M | ||
| Deferred revenue | $56.1M | $53.3M | ||
| Operating lease liabilities | $3.8M | $3.6M | ||
| Current portion of long-term debt | $1.6M | $231.2M | ||
| Total current liabilities | $89.6M | $325.9M | ||
| Long-term debt, net of current portion | $151.6M | $151.2M | ||
| Deferred revenue, net of current portion | $410.0K | $249.0K | ||
| Operating lease liabilities, net of current portion | $14.2M | $16.3M | ||
| Contingent consideration liabilities, net of current portion | $250.0K | $0 | ||
| Other liabilities | $798.0K | $154.0K | ||
| Total liabilities | $256.9M | $493.7M | ||
| Preferred stock, $0.001 par value per share; 25,000,000 shares authorized and no shares issued and outstanding as of December 31, 2025 and 2024 | $0 | $0 | ||
| Common stock, $0.001 par value per share, and additional paid-in capital; 500,000,000 shares authorized as of December 31, 2025 and 2024; 72,027,332 and 64,043,799 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $1.6B | $1.6B | ||
| Accumulated deficit | -$1.4B | -$1.2B | ||
| Accumulated other comprehensive income (loss) | $1.6M | -$835.0K | ||
| Total stockholders equity | $245.8M | $365.2M | $366.9M | $425.0M |
| Total liabilities and stockholders equity | $502.6M | $858.9M | ||
| Preferred stock, par value (in USD per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 25.0M shares | 25.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in USD per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in shares) | 500.0M shares | 500.0M shares | ||
| Common stock, shares issued (in shares) | 72.0M shares | 64.0M shares | ||
| Common stock, shares, outstanding (in shares) | 72.0M shares | 64.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$178.0M | -$69.5M | -$118.1M |
| Stock-based compensation expense | $27.0M | $40.1M | $55.8M |
| Depreciation and amortization | $50.5M | $41.4M | $42.2M |
| Investment discount and premium accretion | -$1.6M | -$4.8M | -$9.7M |
| Impairment of long-lived assets | $6.9M | $2.2M | $4.1M |
| Non-cash operating lease expense | $2.9M | $2.7M | $3.0M |
| Provision for expected credit losses | $1.5M | $1.2M | $1.8M |
| Amortization of debt discount, issuance costs, and deferred financing costs | $3.7M | $3.3M | $1.5M |
| Deferred tax provision | $81.0K | $77.0K | $8.0K |
| Change in fair value of contingent consideration liabilities | -$7.1M | -$1.6M | $0 |
| Impairment of goodwill and intangible assets | $110.2M | $0 | $0 |
| Other | -$429.0K | $141.0K | $67.0K |
| Accounts receivable, net | -$1.8M | $4.3M | -$13.7M |
| Prepaid expenses and other assets | $1.6M | -$50.0K | $164.0K |
| Accounts payable, accrued liabilities, and other liabilities | -$11.5M | $5.6M | $4.9M |
| Deferred revenue | $607.0K | -$7.0M | -$1.5M |
| Operating lease liabilities | -$4.0M | -$3.5M | -$3.6M |
| Net cash provided by (used in) operating activities | $731.0K | $14.6M | -$33.1M |
| Proceeds from the sale and maturity of short-term investments | $163.9M | $242.1M | $336.8M |
| Purchases of short-term investments | -$65.1M | -$168.3M | -$290.8M |
| Capitalization of internal-use software | -$19.8M | -$14.3M | -$12.0M |
| Acquisition of businesses, net of cash acquired | -$41.1M | -$80.3M | -$11.4M |
| Purchases of property and equipment | -$968.0K | -$1.6M | -$1.2M |
| Purchases of intangible assets | -$805.0K | -$508.0K | -$1.1M |
| Proceeds from the sale of property and equipment | $44.0K | $13.0K | $31.0K |
| Net cash provided by (used in) investing activities | $36.2M | -$22.9M | $20.3M |
| Proceeds from issuance of long-term debt, net of issuance costs | $0 | $152.3M | $0 |
| Payment of deferred financing costs | $0 | -$2.2M | $0 |
| Repayment of debt | $232.3M | $959.0K | $0 |
| Proceeds from employee stock purchase plan | $1.5M | $2.4M | $3.6M |
| Proceeds from exercise of stock options | $0 | $169.0K | $950.0K |
| Repurchase of common stock | -$5.0M | $0 | -$1.8M |
| Net cash (used in) provided by financing activities | -$235.8M | $151.7M | $2.7M |
| Effect of exchange rate changes on cash and cash equivalents | $27.0K | -$34.0K | $21.0K |
| Net (decrease) increase in cash and cash equivalents | -$198.8M | $143.4M | -$10.0M |
| Cash paid for interest | $21.9M | $10.1M | $5.8M |
| Common stock issued in connection with business acquisitions | $31.6M | $24.9M | $0 |
| Operating lease right-of-use assets obtained in exchange for operating lease obligations | $806.0K | $1.3M | $2.0M |
| Stock-based compensation capitalized as internal-use software | $1.0M | $1.0M | $889.0K |
| Capitalized internal-use software included in accounts payable and accrued liabilities | $189.0K | $265.0K | $169.0K |
| Purchase of property and equipment included in accounts payable and accrued liabilities | $76.0K | $13.0K | $7.0K |
| Purchase of intangible assets included in accounts payable and accrued liabilities | $1.7M | $0 | $1.3M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Health Catalyst, Inc., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerBenjamin Albert Feb 27, 2026 to Sep 16, 202613
- Chief executive officerSimeon Kohl Sep 16, 2026 to now14
- Chief executive officerDaniel D. Burton Jul 24, 2019 to Feb 27, 202615
- PresidentBenjamin Albert Sep 26, 2025 to now16
- PresidentJames Patrick Nelli Jr. Feb 22, 2021 to Sep 6, 202217
- Chief financial officerJason Alger Mar 5, 2024 to now18
- Chief financial officerBryan Truman Hunt Jan 11, 2021 to Mar 5, 202419
- Chief financial officerJames Patrick Nelli Jr. Jul 24, 2019 to Dec 17, 202020
- Chief operating officerBenjamin Albert Sep 26, 2025 to now16
- Chief operating officerDaniel Lesueur Mar 5, 2024 to Sep 26, 202521
- Chief operating officerAnne Marie Bickmore Apr 13, 2023 to Dec 5, 202322
- Chief operating officerDale Sanders Jul 24, 2019 to Jul 24, 201923
- Chief operating officerPaul Horstmeier Jul 24, 2019 to Mar 24, 202324
Board members and other officers (26)
- Chief Growth OfficerKevin Lee Freeman Sep 12, 2022 to now25
- Chief Accounting OfficerJason Alger Jan 11, 2021 to Feb 22, 202426
- Chief Technology OfficerBryan Richard Hinton Apr 8, 2021 to Sep 6, 202227
- Chief Technology OfficerDale Sanders Jan 2, 2020 to Sep 3, 202028
- Chief People OfficerLinda Llewelyn Jul 24, 2019 to now29
- Board memberBenjamin Albert Feb 27, 2026 to now13
- Board memberSteven H. Nelson May 4, 2026 to now30
- Board memberSimeon Kohl Sep 16, 2026 to now14
- Board memberJustin Spencer Sep 3, 2025 to now31
- Board memberMathew Paul Arens Dec 3, 2025 to now32
- Board memberGreen Jill Hoggard Dec 4, 2024 to now33
- Board memberMatthew Kolb Jul 11, 2023 to Jul 11, 202334
- Board memberDawn Smith Jan 2, 2020 to now35
- Board memberJulie Larson-Green Jan 2, 2020 to now36
- Board memberMark B. Templeton Jun 17, 2020 to Jun 16, 202337
- Board memberAnita Pramoda Jul 24, 2019 to Dec 3, 202438
- Board memberD. Fraser Bullock Jul 24, 2019 to Jun 14, 202139
- Board memberDaniel D. Burton Jul 24, 2019 to now15
- Board memberDuncan Gallagher Jul 24, 2019 to now40
- Board memberJohn A. Kane Jul 24, 2019 to now41
- Board memberMichael Edward Dixon Jul 24, 2019 to Jun 17, 202042
- Board memberPromod Haque Jul 24, 2019 to Jan 23, 202043
- Board memberTimothy G. Ferris Jul 24, 2019 to Jan 13, 202144
- Board memberTodd C. Cozzens Jul 24, 2019 to Jun 17, 202045
- General counselBenjamin Landry May 4, 2023 to now46
- General counselDaniel H. Orenstein Jul 24, 2019 to Mar 3, 202347
Named in SEC Form D filings
People the company listed in its private-offering notices.
Former names
- HQC Holdings, Inc.Mar 27, 2015 to Feb 19, 20163
Timeline
Filings
627 filings to the SEC since October 2021: 8 annual reports, 15 quarterly reports, 48 major events, 334 insider forms, 47 large holders, 6 private raises, 169 other. The latest 20:
- Oct 5, 20264 PRIMARY DOCUMENT EDGAR
- Oct 5, 20263 PRIMARY DOCUMENT EDGAR
- Sep 16, 20264 PRIMARY DOCUMENT EDGAR
- Sep 16, 20263 PRIMARY DOCUMENT EDGAR
- Sep 14, 2026S-8 EDGAR
- Sep 14, 20268-K EDGAR
- Sep 11, 20264 PRIMARY DOCUMENT EDGAR
- Sep 10, 2026144 EDGAR
- Sep 8, 20268-K EDGAR
- Sep 8, 2026SCHEDULE 13D/A EDGAR
- Sep 3, 20264 PRIMARY DOCUMENT EDGAR
- Sep 3, 20264 PRIMARY DOCUMENT EDGAR
- Sep 3, 20264 PRIMARY DOCUMENT EDGAR
- Sep 3, 20264 PRIMARY DOCUMENT EDGAR
- Sep 1, 2026144 EDGAR
- Sep 1, 2026144 EDGAR
- Sep 1, 2026144 EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 6, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
The 627 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
122 open-market trades by officers, directors and large owners since October 2021: 8 buys and 114 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Kohl SimeonChief Executive Officer | Buy | 59,000 | $1.79 | $105.6K | Form 4 |
| Dec 5, 2025 | Landry BenjaminGeneral Counsel | Sale | 27,425 | $2.64 | $72.4K | Form 4 |
| Dec 4, 2025 | Larson-Green JulieDirector | Sale | 47,997 | $2.67 | $128.2K | Form 4 |
| Sep 5, 2025 | Landry BenjaminGeneral Counsel | Sale | 6,175 | $3.35 | $20.7K | Form 4 |
| Jun 5, 2025 | Landry BenjaminGeneral Counsel | Sale | 6,057 | $3.94 | $23.9K | Form 4 |
| May 5, 2025 | LeSueur DanielChief Operating Officer | Sale | 5,209 | $4.10 | $21.4K | Form 4 |
| Apr 3, 2025 | LeSueur DanielChief Operating Officer | Sale | 5,209 | $4.15 | $21.6K | Form 4 |
| Mar 6, 2025 | Landry BenjaminGeneral Counsel | Sale | 13,827 | $4.55 | $62.9K | Form 4 |
| Mar 5, 2025 | LeSueur DanielChief Operating Officer | Sale | 16,902 | $4.52 | $76.4K | Form 4 |
| Feb 18, 2025 | Llewelyn LindaChief People Officer | Sale | 6,441 | $5.43 | $35.0K | Form 4 |
| Feb 5, 2025 | LeSueur DanielChief Operating Officer | Sale | 5,209 | $5.76 | $30.0K | Form 4 |
| Jan 15, 2025 | Llewelyn LindaChief People Officer | Sale | 6,442 | $5.80 | $37.4K | Form 4 |
| Jan 6, 2025 | LeSueur DanielChief Operating Officer | Sale | 5,209 | $7.51 | $39.1K | Form 4 |
| Jan 6, 2025 | Landry BenjaminGeneral Counsel | Sale | 2,500 | $7.52 | $18.8K | Form 4 |
| Dec 30, 2024 | Gallagher DuncanDirector | Sale | 4,500 | $6.93 | $31.2K | Form 4 |
| Dec 23, 2024 | Gallagher DuncanDirector | Sale | 4,500 | $6.98 | $31.4K | Form 4 |
| Dec 16, 2024 | Llewelyn LindaChief People Officer | Sale | 6,442 | $7.88 | $50.8K | Form 4 |
| Dec 6, 2024 | Alger JasonChief Financial Officer | Sale | 19,599 | $8.32 | $163.1K | Form 4 |
| Dec 6, 2024 | Landry BenjaminGeneral Counsel | Sale | 19,268 | $8.32 | $160.3K | Form 4 |
| Dec 4, 2024 | LeSueur DanielChief Operating Officer | Sale | 22,773 | $7.70 | $175.4K | Form 4 |
All 122 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Palogic Value Management, L.P.SCHEDULE 13D/A, 2 filings Jun 22, 2026 to Sep 8, 202650
- Stoney Lonesome HF LPSCHEDULE 13G/A, 3 filings Dec 22, 2025 to Aug 14, 202651
- BlackRockSCHEDULE 13G/A, 1 filing Jul 28, 202652
- Impax Asset Management Group plcSCHEDULE 13G, 1 filing Jul 21, 202653
- Whetstone Capital Advisors, LLCSCHEDULE 13D/A, 5 filings Sep 8, 2025 to Jun 8, 202654
- VANGUARD GROUP INCSCHEDULE 13G/A, 8 filings Feb 10, 2022 to Mar 27, 202655
- First Light Asset Management, LLCSCHEDULE 13D/A, 6 filings Nov 14, 2024 to Mar 13, 202656
- Point72 Asset Management, L.P.SC 13G/A, 5 filings Nov 3, 2022 to Nov 14, 202457
- Wellington Management CompanySC 13G/A, 4 filings Feb 4, 2022 to Nov 8, 202458
- Capital Research Global InvestorsSC 13G/A, 2 filings Feb 11, 2022 to Feb 13, 202359
- MILLENNIUM MANAGEMENT LLCSC 13G/A, 2 filings Aug 30, 2022 to Jan 13, 202360
- FMR LLCSC 13G/A, 3 filings Feb 9, 2022 to Jun 10, 202261
Money raised
Private offerings the company reported to the SEC on Form D.
- Jan 22, 2025Raised $44.5 million in a private offering of equity Form D: 109 investors so far Form D
- Nov 8, 2024Raised $18 million in a private offering of equity Form D: 10 investors so far Form D
- Aug 1, 2024Raised $2.5 million in a private offering of equity Form D: 7 investors so far Form D
- May 24, 2024Raised $2.5 million in a private offering of equity Form D: 13 investors so far Form D
- Apr 29, 2022Raised $6 million in a private offering of equity Form D: 3 investors so far Form D
- Feb 24, 2022Raised $13.5 million in a private offering of equity Form D: 16 investors so far Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| First Light Asset Management, LLC | 12,810,861 | $25.5M | 1.5% | −67,839 |
| CDC Financial, Inc. | 7,092,698 | $14.1M | 10.8% | +785,644 |
| Palogic Value Management, L.P. | 4,922,442 | $9.8M | 3.5% | +2,025,842 |
| Impax Asset Management Group plc | 4,000,000 | $8.0M | 0.1% | +1,250,000 |
| Nepsis Inc. | 2,976,187 | $5.9M | 2.0% | +1,099,898 |
| Vanguard Capital Management LLC | 2,971,598 | $5.9M | 0.0% | +85,945 |
| BlackRock, Inc. | 1,836,373 | $3.7M | 0.0% | −3,301,649 |
| Jane Street Group, LLC | 1,037,782 | $2.1M | 0.0% | +1,011,214 |
| Dimensional Fund Advisors LP | 911,819 | $1.8M | 0.0% | −323,051 |
| Geode Capital Management, LLC | 891,357 | $1.8M | 0.0% | −610,076 |
| HighMark Wealth Management LLC | 871,082 | $1.7M | 0.6% | −32,000 |
| Caption Management, LLC | 773,650 | $1.5M | 0.1% | +1,764 |
| Mink Brook Asset Management LLC | 738,277 | $1.5M | 0.6% | New |
| Prescott Group Capital Management, L.L.C. | 710,803 | $1.4M | 0.1% | No change |
| Charles Schwab Investment Management Inc | 615,504 | $1.2M | 0.0% | +8,646 |
| Millennium Management LLC | 516,083 | $1.0M | 0.0% | New |
| Goldman Sachs Group Inc | 480,970 | $957.1K | 0.0% | +93,798 |
| Vanguard Fiduciary Trust Co | 463,005 | $921.4K | 0.0% | +19,340 |
| Citadel Advisors LLC | 453,214 | $901.9K | 0.0% | New |
| Susquehanna International Group, Llp | 437,227 | $870.1K | 0.0% | +356,073 |
| Fmr LLC | 410,637 | $817.2K | 0.0% | +43,164 |
| Hsbc Holdings PLC | 408,634 | $809.1K | 0.0% | +309,766 |
| Squarepoint Ops LLC | 400,210 | $796.4K | 0.0% | +369,772 |
| Aqr Capital Management LLC | 376,586 | $749.4K | 0.0% | −166,658 |
| State Street Corp | 360,713 | $717.8K | 0.0% | −964,136 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARSimeon Kohl, Chief executive officer
- 15
- 16SEC EDGARBenjamin Albert, President
- 17SEC EDGARJames Patrick Nelli Jr., President
- 18SEC EDGARJason Alger, Chief financial officer
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29SEC EDGARLinda Llewelyn, Chief People Officer
- 30SEC EDGARSteven H. Nelson, Board member
- 31SEC EDGARJustin Spencer, Board member
- 32SEC EDGARMathew Paul Arens, Board member
- 33SEC EDGARGreen Jill Hoggard, Board member
- 34SEC EDGARMatthew Kolb, Board member
- 35SEC EDGARDawn Smith, Board member
- 36SEC EDGARJulie Larson-Green, Board member
- 37SEC EDGARMark B. Templeton, Board member
- 38SEC EDGARAnita Pramoda, Board member
- 39SEC EDGARD. Fraser Bullock, Board member
- 40SEC EDGARDuncan Gallagher, Board member
- 41SEC EDGARJohn A. Kane, Board member
- 42SEC EDGARMichael Edward Dixon, Board member
- 43SEC EDGARPromod Haque, Board member
- 44SEC EDGARTimothy G. Ferris, Board member
- 45SEC EDGARTodd C. Cozzens, Board member
- 46SEC EDGARBenjamin Landry, General counsel
- 47SEC EDGARDaniel H. Orenstein, General counsel
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61